Trial No. Principal Investigator Trial Name
CA209-374 Babu A phase 3b/4 safety trial of Nivolumab (BMS-936558) in subjects with advanced or metastatic renal cell carcinoma CheckMate 374: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 374